Cidara Therapeutics
CDTX
CDTX
54 hedge funds and large institutions have $83.6M invested in Cidara Therapeutics in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
–
Holders Change %
0%
% of All Funds
1.35%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
21
Increased
10
Reduced
12
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$2.8M |
| 2 |
BC
Broadfin Capital
New York
|
+$1.9M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$1.13M |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$1.07M |
| 5 |
Renaissance Technologies
New York
|
+$750K |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$5.72M |
| 2 |
BlackRock
New York
|
-$3.99M |
| 3 |
State Street
Boston,
Massachusetts
|
-$970K |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$955K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$712K |
